Zhejiang Huakang Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 942.97 million compared to CNY 727.86 million a year ago. Revenue was CNY 949.97 million compared to CNY 731.18 million a year ago. Net income was CNY 141.94 million compared to CNY 115.71 million a year ago. Basic earnings per share from continuing operations was CNY 0.62 compared to CNY 0.54 a year ago. Diluted earnings per share from continuing operations was CNY 0.62 compared to CNY 0.54 a year ago.